Hospital
Hazel Hawkins Memorial Hospital
Hazel Hawkins Memorial Hospital was paid $23.82M by Medicaid between Jan 2018 and Dec 2024, across 256 billing codes. Its largest line is 0121, — 22% of everything it billed.
33Billing provider infoHAZEL HAWKINS MEMORIAL HOSPITAL
HOLLISTER, CA 95023
HOLLISTER, CA 95023
33aNPI1275578817assigned 06/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$23.82M
24GClaims504,803
24DCodes billed256
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#108 of 410
Median peer was paid$6.90M
This provider vs. median3.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36,941 | $1.00M | |
| 2019 | 39,787 | $1.12M | |
| 2020 | 44,343 | $1.22M | |
| 2021 | 67,361 | $2.34M | |
| 2022 | 80,226 | $2.71M | |
| 2023 | 103,368 | $3.62M | |
| 2024incomplete | 132,777 | $11.82M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0121 | 22% | 281 | 277 | $5.12M | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 20% | 11,900 | 11,003 | $4.71M |
| 0122 | 4.3% | 56 | 56 | $1.02M | |
| Z7502 | 3.8% | 24,161 | 23,213 | $900K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.6% | 12,858 | 11,210 | $849K |
| 99199 | Unlisted special service, procedure or report | 3.4% | 16,180 | 13,540 | $810K |
| 0450 | Emergency room services | 2.7% | 14,276 | 12,589 | $635K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.4% | 3,363 | 3,264 | $563K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.3% | 10,988 | 10,642 | $555K |
| 87486 | 2.2% | 11,398 | 11,048 | $521K | |
| 87581 | 2.1% | 11,402 | 11,051 | $508K | |
| 80053 | Comprehensive metabolic panel | 2.0% | 37,268 | 34,329 | $477K |
244 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 38,745 | $358K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 1,370 | $283K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.2% | 12,539 | $276K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 18,544 | $211K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,630 | $204K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,991 | $201K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 9,017 | $198K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,899 | $183K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,899 | $181K |
| Z7610 | <1% | 14,726 | $181K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 6,258 | $180K |
| 80061 | Lipid panel | <1% | 10,385 | $170K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 7,704 | $158K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,255 | $146K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,862 | $133K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,204 | $130K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,841 | $126K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,443 | $126K |
| 99460 | <1% | 121 | $125K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,049 | $121K |
| 87631 | <1% | 1,995 | $121K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,104 | $117K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 510 | $111K |
| 84439 | <1% | 8,694 | $104K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,824 | $101K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,427 | $99K |
| 87507 | <1% | 212 | $98K | |
| 83690 | <1% | 11,307 | $92K | |
| 83880 | <1% | 3,241 | $92K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,327 | $92K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,289 | $89K |
| 76830 | Ultrasound, transvaginal | <1% | 1,106 | $77K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,209 | $76K |
| 84484 | <1% | 6,730 | $73K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 827 | $70K |
| 97139 | <1% | 3,041 | $66K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,371 | $65K |
| 71250 | <1% | 230 | $61K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 114 | $60K |
| 80150 | <1% | 3,587 | $55K | |
| 81025 | <1% | 6,667 | $50K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 551 | $50K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,586 | $49K |
| 76801 | <1% | 891 | $47K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,110 | $47K |
| 94664 | <1% | 3,229 | $46K | |
| 84145 | <1% | 2,182 | $45K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,715 | $43K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,162 | $43K |
| 80055 | <1% | 722 | $42K | |
| 82542 | <1% | 1,698 | $41K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,424 | $40K |
| 86803 | <1% | 1,843 | $37K | |
| 81001 | <1% | 9,157 | $36K | |
| 81003 | <1% | 11,718 | $30K | |
| 83605 | <1% | 2,197 | $26K | |
| 86140 | <1% | 4,096 | $26K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,086 | $25K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 524 | $25K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 352 | $24K |
| 59025 | Fetal non-stress test | <1% | 864 | $23K |
| 99223 | Prolong inpt eval add15 m | <1% | 305 | $22K |
| 82728 | <1% | 1,614 | $22K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,785 | $21K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 25 | $21K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,879 | $20K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,028 | $20K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,823 | $20K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 466 | $18K |
| 99243 | <1% | 244 | $18K | |
| 73610 | <1% | 601 | $18K | |
| 76536 | <1% | 233 | $18K | |
| 73630 | <1% | 671 | $18K | |
| 99283 | Emergency room visit (moderate) | <1% | 241 | $17K |
| 72131 | <1% | 56 | $17K | |
| 73030 | <1% | 549 | $17K | |
| 81513 | <1% | 94 | $16K | |
| 80143 | <1% | 1,071 | $16K | |
| 83550 | <1% | 1,586 | $16K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 242 | $16K |
| 99284 | Emergency room visit (serious) | <1% | 105 | $16K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 308 | $16K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 818 | $15K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 356 | $15K |
| 76770 | <1% | 139 | $15K | |
| 80179 | <1% | 978 | $15K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 84 | $15K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 25 | $14K |
| 83540 | <1% | 1,713 | $14K | |
| 73562 | <1% | 495 | $13K | |
| 83735 | <1% | 1,708 | $13K | |
| 93307 | <1% | 168 | $12K | |
| 84702 | <1% | 1,136 | $12K | |
| J3490 | Unclassified drugs | <1% | 464 | $12K |
| 77066 | Tomosynthesis, mammo | <1% | 78 | $11K |
| 82043 | <1% | 1,350 | $11K | |
| 87186 | <1% | 1,707 | $10K | |
| 76982 | <1% | 112 | $10K | |
| 93971 | <1% | 64 | $10K | |
| 87040 | <1% | 953 | $10K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,964 | $9K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 958 | $9K |
| 82607 | <1% | 805 | $9K | |
| 82746 | <1% | 425 | $9K | |
| 87077 | <1% | 1,922 | $9K | |
| 74018 | <1% | 415 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 816 | $8K |
| 85730 | <1% | 1,263 | $8K | |
| 73110 | <1% | 245 | $8K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 517 | $8K |
| 76642 | <1% | 132 | $8K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 241 | $7K |
| 73130 | <1% | 244 | $7K | |
| 0762 | <1% | 153 | $7K | |
| 99285 | Emergency room visit (most serious) | <1% | 46 | $7K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 174 | $7K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,287 | $7K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 172 | $6K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 264 | $6K |
| 85651 | <1% | 1,341 | $6K | |
| 84436 | <1% | 664 | $5K | |
| 82550 | <1% | 793 | $5K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 838 | $5K |
| 87481 | <1% | 96 | $5K | |
| 85610 | <1% | 1,080 | $5K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 934 | $5K |
| 87420 | <1% | 425 | $5K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 634 | $5K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 38 | $5K |
| 73700 | <1% | 13 | $4K | |
| 97161 | <1% | 81 | $4K | |
| 87081 | <1% | 457 | $4K | |
| 99000 | <1% | 1,210 | $4K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 69 | $4K |
| 97035 | <1% | 295 | $4K | |
| 93000 | <1% | 105 | $4K | |
| 0011A | <1% | 91 | $4K | |
| 72100 | <1% | 86 | $4K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 108 | $3K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 570 | $3K |
| 97010 | <1% | 199 | $3K | |
| 0012A | <1% | 83 | $3K | |
| 84153 | <1% | 120 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 270 | $3K |
| 86850 | <1% | 239 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 132 | $3K |
| 0160 | <1% | 48 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 100 | $3K |
| 87070 | <1% | 231 | $3K | |
| 76641 | <1% | 44 | $3K | |
| 86592 | <1% | 515 | $3K | |
| 82950 | <1% | 381 | $2K | |
| 80299 | <1% | 151 | $2K | |
| 73560 | <1% | 93 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 70 | $2K |
| 90715 | <1% | 38 | $2K | |
| 73564 | <1% | 57 | $2K | |
| 99462 | <1% | 67 | $2K | |
| 82150 | <1% | 209 | $2K | |
| 96367 | <1% | 38 | $2K | |
| 73502 | <1% | 38 | $2K | |
| 87634 | <1% | 29 | $2K | |
| 0270 | <1% | 766 | $2K | |
| 73080 | <1% | 42 | $1K | |
| 97014 | <1% | 75 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 117 | $1K |
| 73140 | <1% | 62 | $1K | |
| 0721 | <1% | 65 | $1K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 29 | $1K |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 95 | $1K |
| 0004A | <1% | 29 | $1K | |
| 82140 | <1% | 77 | $1K | |
| 0064A | <1% | 26 | $1K | |
| 86308 | <1% | 137 | $1K | |
| Z7500 | <1% | 29 | $988.90 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 51 | $977.54 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 23 | $970.05 |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 12 | $969.36 |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 41 | $950.38 |
| 72110 | <1% | 13 | $933.17 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 12 | $900.82 |
| 82570 | <1% | 105 | $827.59 | |
| 83970 | <1% | 13 | $821.08 | |
| 85044 | <1% | 117 | $771.03 | |
| 84550 | <1% | 128 | $751.72 | |
| 84100 | <1% | 105 | $717.75 | |
| 85027 | <1% | 74 | $693.00 | |
| 87641 | <1% | 14 | $661.50 | |
| 84156 | <1% | 129 | $640.35 | |
| 85378 | <1% | 40 | $553.15 | |
| 82977 | <1% | 58 | $542.70 | |
| 0071A | <1% | 13 | $520.00 | |
| 0002A | <1% | 13 | $520.00 | |
| J2704 | Injection, propofol, 10 mg | <1% | 130 | $515.89 |
| 84460 | <1% | 68 | $486.60 | |
| X3910 | <1% | 47 | $462.48 | |
| 99001 | <1% | 2,394 | $438.02 | |
| 93225 | <1% | 12 | $414.15 | |
| 82947 | <1% | 69 | $297.91 | |
| 87071 | <1% | 40 | $279.65 | |
| 81002 | <1% | 141 | $278.21 | |
| 86430 | <1% | 29 | $262.92 | |
| 82010 | <1% | 28 | $237.29 | |
| 82951 | <1% | 12 | $236.28 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 41 | $223.97 |
| 93244 | <1% | 12 | $190.59 | |
| 29515 | <1% | 14 | $184.38 | |
| 82247 | <1% | 21 | $153.60 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 30 | $149.45 |
| 96376 | <1% | 42 | $135.30 | |
| 82248 | <1% | 17 | $130.56 | |
| 0251 | <1% | 129 | $94.30 | |
| 0250 | <1% | 188 | $92.90 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 12 | $82.08 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 12 | $67.06 |
| 0300 | <1% | 437 | $50.26 | |
| 96379 | <1% | 314 | $24.00 | |
| A9270 | Non-covered item or service | <1% | 345 | $16.20 |
| 0306 | <1% | 213 | $15.23 | |
| 0258 | <1% | 437 | $11.78 | |
| 0636 | <1% | 325 | $9.74 | |
| 0301 | <1% | 311 | $9.65 | |
| 0637 | <1% | 51 | $5.40 | |
| 0305 | <1% | 401 | $4.97 | |
| 81015 | <1% | 44 | $3.05 | |
| 0307 | <1% | 212 | $2.03 | |
| 3074F | 0% | 124 | $0.00 | |
| 0259R | 0% | 159 | $0.00 | |
| 0271R | 0% | 111 | $0.00 | |
| 0324 | 0% | 96 | $0.00 | |
| 0720 | 0% | 13 | $0.00 | |
| 80320 | 0% | 30 | $0.00 | |
| 0352 | 0% | 70 | $0.00 | |
| 0250R | 0% | 173 | $0.00 | |
| 0302 | 0% | 316 | $0.00 | |
| 0258R | 0% | 53 | $0.00 | |
| 0272R | 0% | 228 | $0.00 | |
| 0730 | 0% | 97 | $0.00 | |
| 0460 | 0% | 90 | $0.00 | |
| 3078F | 0% | 133 | $0.00 | |
| 0470 | 0% | 27 | $0.00 | |
| 0252 | 0% | 38 | $0.00 | |
| 0412 | 0% | 14 | $0.00 | |
| 0272 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCASILLAS, MARY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Hazel Hawkins Memorial Hospital | Hollister, CA | $14.76M |
| Hazel Hawkins Memorial Hospital | Hollister, CA | $10.06M |
| Hazel Hawkins Memorial Hospital | Hollister, CA | $8.27M |
| Hazel Hawkins Memorial Hospital | Hollister, CA | $5.74M |
| Hazel Hawkins Memorial Hospital | San Juan Bautista, CA | $2.72M |
| Hazel Hawkins Memorial Hospital | Hollister, CA | $5K |
| Hazel Hawkins Hospital | Hollister, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.